Log In
BCIQ
Print this Print this
 

VTI-1002

  Manage Alerts
Collapse Summary General Information
Company viDA Therapeutics Inc.
DescriptionTopical small molecule granzyme B (GrB; GZMB) inhibitor
Molecular Target Granzyme B (GrB) (GZMB)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationLupus
Indication DetailsTreat discoid lupus erythematosus (DLE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/22/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today